Stay updated on GA 40 mg Injection vs Placebo in RRMS - Clinical Trial
Sign up to get notified when there's something new on the GA 40 mg Injection vs Placebo in RRMS - Clinical Trial page.

Latest updates to the GA 40 mg Injection vs Placebo in RRMS - Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference2%

- Check32 days agoChange DetectedCore page content is largely unchanged; however, several MedlinePlus topics were removed and the page revision updated to v3.1.0, indicating a cleanup of topics rather than addition of new content.SummaryDifference0.3%

- Check46 days agoChange DetectedPage updated to Revision: v3.0.2, replacing v3.0.1; a minor UI element 'Back to Top' was removed.SummaryDifference0.1%

- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check60 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, as well as the introduction of new drug safety topics. Notably, the term 'Glatiramer Acetate' has been retained despite its deletion in a previous context, indicating a focus on this drug's relevance.SummaryDifference7%

- Check75 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.0%

Stay in the know with updates to GA 40 mg Injection vs Placebo in RRMS - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GA 40 mg Injection vs Placebo in RRMS - Clinical Trial page.